Key Corporate Developments: Anhui Conch Cement Company Limited (00914) plans to acquire a 100% equity stake in Conch Design Institute for approximately RMB 561.6 million. JL MAG Rare-Earth Co., Ltd. (06680) intends to acquire a 9.24% stake in Baotou Rare Earth Products Exchange Co., Ltd. Shenzhen Senior Technology Material Co., Ltd. (06067) plans to invest RMB 151 million to participate in establishing an industry fund targeting investments across the entire novel energy storage industry chain. (02431) has signed a sales contract for unmanned logistics vehicles. Mabwell (Shanghai) Bioscience Co., Ltd. (02493): The clinical trial application for the 9MW5211 injection has been approved by the National Medical Products Administration. (02181): The new drug application for CMAB807X (Denosumab Injection) has received approval.

Operational and Financial Results: Trip.com Group Limited (09961) reported a 17% year-on-year increase in net operating revenue for the first quarter, reaching RMB 16.2 billion. (01050) announced that its revenue for the 2026 fiscal year reached a recent high, with adjusted net profit rising 48.3% year-on-year to HK$303 million and a full-year dividend per share of 6 HK cents. Bright Smart Securities & Commodities Group Limited (01428) released its annual results, reporting a profit attributable to shareholders of HK$670 million, an increase of 8.52% year-on-year. Gangzi Robot Co., Ltd. (00370) published its annual results, showing revenue of HK$186 million, a 75.3% year-on-year increase. Chen Hsong Holdings Limited (00057) issued its annual results, with profit attributable to shareholders at HK$117 million, a decrease of 24% year-on-year.